MKMeenal Kheterpal

Meenal Kheterpal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Meenal Kheterpal has a total of 72 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Economic evaluation of added neoadjuvant cemiplimab to upfront wide local excision for advanced cutaneous squamous cell carcinoma of the head and neck

    by Christian L. Bailey-Burke, David M. Brizel, Peter A. Ubel, Shelby D. Reed, Meenal K. Kheterpal

  • Open Access

    Assessing Treatment Response to PD-1 Inhibitors in Cutaneous Squamous Cell Carcinoma: Real-World Challenges

    by Kristin Tissera, Olivia S. Suarez-Jew, Meenal Kheterpal

    Introduction: Cutaneous squamous cell carcinoma (cSCC) is a common nonmelanoma skin cancer primarily driven by chronic sun exposure and advanced age. Standard treatments include wide local excision, Mohs surgery, and radiotherapy, with advanced cases often managed with chemotherapeutics. PD1 inhibitors like cemiplimab and pembrolizumab are FDA-approved treatments that have shown efficacy in locally advanced or metastatic cSCC not amenable to surgery or radiation. Objectives: This study evaluated clinical responses to these inhibitors using RECIST 1.1 criteria through direct visual examination, addressing the applicability of the criteria in real-world clinical practice. Methods: A cohort of 12 patients with cSCC treated at Duke University with cemiplimab or pembrolizumab was identified through the DeDUCE database using ICD-10 codes. Clinical responses were determined using RECIST 1.1 and modified WHO criteria and compared against clinical-based assessments. Results: Results indicated varied responses: seven patients with progressive disease (PD), two with stable disease (SD), and three with complete response (CR). Challenges included distinguishing true progression from reactive conditions like erosive pustular dermatosis (EPD) and pseudoprogression as well as evaluating partial responses in ulcerated lesions, which are not defined within the criteria. Radiologic findings often required corroboration with clinical evaluations to avoid misclassification. Conclusions: Accurate clinical determination of cSCC response to PD-1 inhibitors is complex, requiring multidisciplinary approaches and meticulous wound care. Incorporating these clinical nuances into revised response criteria would enhance treatment decision-making, balancing the risks of premature discontinuation against prolonged ineffective therapy.

  • Open Access

    Assessing Treatment Efficacy for Dermatologic Immune-Related Adverse Events: A Systematic Review

    by Christian L. Bailey-Burke, Kristin A. Tissera, Lauren Baughman, Samantha A. Polly, Meenal Kheterpal


  • Open Access

    Cladribine Use in Xanthoma Disseminatum: A Rare Case Presentation and Brief Updated Literature Review

    by Matthew M. Gayed, Olivia S. Jew, Rami N. Al-Rohil, Meenal Kheterpal

    Xanthoma disseminatum (XD) is a rare, non-Langerhans cell histiocytosis. While treatment is notoriously difficult, 2-chlorodeoxyadenosine (cladribine) has recently emerged as a potential effective therapeutic option. Here, we describe the case of a 65-year-old male with XD who experienced significant cutaneous improvement after cladribine treatment. We also provide an updated literature review on cladribine use in patients with XD in light of reported adverse effects (AEs). While the efficacy of cladribine in XD is clear, no consensus exists for treatment duration and AE management. Hence, we strongly encourage interdisciplinary discourse involving dermatology and oncology in these cases.


  • Open Access

    Image Quality Assessment Using Convolutional Neural Network in Clinical Skin Images

    by Hyeon Ki Jeong, Christine Park, Simon W. Jiang, Matilda Nicholas, Suephy Chen, Ricardo Henao, Meenal Kheterpal


  • Open Access

    Implementation evaluation of a teledermatology virtual clinic at an academic medical center

    by Meenal K. Kheterpal, Ethan D. Borre, Udeyvir Cheema, Matilda W. Nicholas, Edward W. Cooner, Donna Phinney, Kelly Gagnon, Leah L. Zullig, Heather A. King, Elizabeth J. Malcolm, et al.

    Background: Teledermatology (TD) is an evidence-based practice that may increase access to dermatologic care. We sought to use the Exploration, Preparation, Implementation, and Sustainment (EPIS) and the Reach, Efficacy, Adoption, Implementation, and Maintenance (RE-AIM) frameworks to evaluate implementation of TD at Duke. Methods: The EPIS and RE-AIM frameworks were deployed to design and implement a TD program that leveraged the strengths of the Duke University Health System and addressed previously reported barriers to implementation of store-and-forward and synchronous TD models. In the resultant hybrid TD model, trained primary care providers (PCPs) sent e-comm referrals with clinical and dermatoscopic images to dermatology. These e-consults were reviewed asynchronously and patients were scheduled for a synchronous video visit with dermatology within days. Dermatologists managed the patient plan. This hybrid TD model was piloted at four primary care clinics. Pertinent outcomes from a TD-adapted RE-AIM framework were tracked using electronic health record data. Patient satisfaction was assessed using a post-video visit survey (n = 18). Implementation barriers and facilitators were also collected through provider surveys (n = 24 PCPs, n = 10 dermatologists, n = 10 dermatology residents). Results: At four PCP clinics throughout 9/1/2021–4/30/2022, there were 218 TD referrals. Video visits occurred on average 7.5 ± 0.5 days after referral and 18/18 patients completing the post-visit survey were satisfied. Adoption varied between clinics, with one placing 22% of all dermatology referrals as TD and another placing 2%. The primary PCP barriers to TD were time burdens, lack of fit in clinic flow, and discomfort with image taking. Top-endorsed potential facilitating interventions included allowing for rash referrals without dermoscopy and assurance for clinical evaluation within 3 days. Conclusions: The use of implementation science frameworks allowed for identification of system and contextual strengths which informed the hybrid TD pilot. Barriers and facilitating interventions will provide guidance for expansion and ongoing maintenance of TD.


  • Open Access

    Implementation Evaluation of a Teledermatology Virtual Clinic at an Academic Medical Center

    by Meenal Kheterpal, Ethan D. Borre, Matilda W. Nicholas, Edward W. Cooner, Donna Phinney, Kelly Gagnon, Leah L. Zullig, Heather A. King, Elizabeth J. Malcolm, Suephy C. Chen

    Background Teledermatology (TD) is an evidence-based practice that may increase access to dermatologic care. We sought to evaluate implementation of TD at four Duke primary care practices. Methods We implemented a hybrid TD program where trained primary care providers (PCPs) sent referrals with clinical and dermatoscopic images to dermatology. Patients were seen by dermatologists over video visit within days, and dermatologists managed the patient plan. We evaluated implementation using the Reach, Efficacy, Adoption, Implementation, and Maintenance (RE-AIM) framework using electronic health record data. Implementation barriers and facilitators were collected through surveys (n = 24 PCPs, n = 10 dermatologists, n = 10 dermatology residents). Results At four PCP clinics throughout 9/1/2021-4/30/2022 there were 218 TD referrals. Video visits occurred on average 7.5 days after referral and 18/18 patients completing the post-visit survey were satisfied. Adoption varied between clinics, with one placing 22% of all dermatology referrals as TD and another placing 2%. The primary PCP barriers to TD were time burdens, lack of fit in clinic flow, and discomfort with image taking. Top-endorsed potential facilitating interventions included allowing for rash referrals without dermoscopy and assurance for clinical evaluation within 3 days. Conclusions Addressing TD process fit into PCP clinic flow and reducing time burdens may increase PCP uptake of TD.

  • Open Access

    Teledermatology May Benefit Marginalized Populations: National and Institutional Trends during the COVID-19 Pandemic

    by Akash D. Patel, Chandler W. Rundle, Beiyu Liu, Cynthia L. Green, Christian L. Bailey-Burke, Meenal Kheterpal

    Introduction Limited data exist regarding demographic-specific teledermatology (TD) utilization during the coronavirus disease 2019 (COVID-19) pandemic. This study aimed to determine TD utilization trends during the pandemic. Methods A retrospective cohort study for national and institutional populations was conducted. Patient encounters in the American Academy of Dermatology’s DataDerm registry (DataDerm) were analyzed from 1 April 2020 through 30 June 2021. All dermatological patients seen by Duke University Health Systems (DUHS) were analyzed from 1 March 2020 through 30 April 2021. In-person clinic visits versus TD encounters (national and institutional) and no-show rates (institutional only) were collected for visit type (i.e., TD versus in-person), sex, race, age/generation, and in- versus out-of-state location (national only). TD utilization is defined as the cohort of interest using TD (e.g., females, whites) within a demographic group (i.e., sex, race) as a percentage of total TD users. This was compared with in-person utilization during the identical timeframe. Results For US national data, 13,964,816 encounters were analyzed. Sex, race, age, and location each had a significant association with TD utilization (adjusted p < 0.001). For institutional data, 54,400 encounters were analyzed. Sex, race, and age had a significant association with TD utilization (adjusted p < 0.001). Both datasets revealed majority female populations for telehealth visits (DataDerm 66.0%; DUHS 61.7%). Non-white populations accounted for a higher percentage of TD utilizers (DataDerm 15.0%; DUHS 37.3%) when compared with in-person utilizers (DataDerm 11.7%; DUHS 22.3%). Younger patients utilized TD (DataDerm 63.6%; DUHS 62.6%) more than in-person services (DataDerm 26.3%; DUHS 43.8%). Institutional no-show rates between telehealth and in-person visits were lower for Black patients (11.8% versus 19.2%), other non-white races (10.6% versus 13.6%), and younger ages/generations (9.8% versus 12.8%), respectively. TD utilization decreased over time nationally as a percentage of total visits (2.9% versus 0.3%) in 2020 versus 2021, respectively. Conclusions and Relevance During the COVID-19 pandemic, certain populations (females, younger patients, non-white races) showed higher TD utilization. Understanding TD utilization trends is critical in defining the role of virtual care for improving universal care access, optimizing resources, and informing future healthcare models for all patient populations.


  • Open Access

    Lesion identification and malignancy prediction from clinical dermatological images

    by Meng Xia, Meenal K. Kheterpal, Samantha C. Wong, Christine Park, William Ratliff, Lawrence Carin, Ricardo Henao

    We consider machine-learning-based lesion identification and malignancy prediction from clinical dermatological images, which can be indistinctly acquired via smartphone or dermoscopy capture. Additionally, we do not assume that images contain single lesions, thus the framework supports both focal or wide-field images. Specifically, we propose a two-stage approach in which we first identify all lesions present in the image regardless of sub-type or likelihood of malignancy, then it estimates their likelihood of malignancy, and through aggregation, it also generates an image-level likelihood of malignancy that can be used for high-level screening processes. Further, we consider augmenting the proposed approach with clinical covariates (from electronic health records) and publicly available data (the ISIC dataset). Comprehensive experiments validated on an independent test dataset demonstrate that (1) the proposed approach outperforms alternative model architectures; (2) the model based on images outperforms a pure clinical model by a large margin, and the combination of images and clinical data does not significantly improves over the image-only model; and (3) the proposed framework offers comparable performance in terms of malignancy classification relative to three board certified dermatologists with different levels of experience.


  • Top Cited Papers
    Open Access

    Deep Learning in Dermatology: A Systematic Review of Current Approaches, Outcomes, and Limitations

    by Hyeon Ki Jeong, Christine Park, Ricardo Henao, Meenal Kheterpal